Article
Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients.
Biochemical pharmacology - 1 Jan 2015
Okubo Maho, Murayama Norie, Miura Jun, Chiba Yasuji, Yamazaki Hiroshi
Abstract excerpt
A personalized treatment approach should be considered with the second-generation psychiatric drug mirtazapine because of high frequencies of side effects, including characteristic drowsiness. Plasma concentrations of mirtazapine in patients are influenced by many factors, including polymorphic cytochrome P450 enzymes contributing to its transformation to 8-hydroxymirtazapine and N-demethylmirtazapine. The aim of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
